What critical neuroendocrine cancer problem/question will researchers try to answer? This research focuses on understanding why pancreatic neuroendocrine tumors (PanNETs) become resistant to current therapies. One of the main treatment strategies for advanced PanNETs is blocking the growth of new blood vessels, which tumors need to survive. The drug sunitinib is approved for this purpose, … Continue reading Elucidating the mechanisms for resistance to antiangiogenic therapy and metastasis in PanNETs